Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2008
11/26/2008CN100435807C Pharmaceutical gel composition
11/26/2008CN100435804C Oral preparation of quick releasing stavudine, and producing method
11/26/2008CN100435798C Preparation of ligustrazine and ligustrazine salt drop pills utilizing nano technology
11/26/2008CN100435797C Oral quick release preparation of indinavir, and preparing method
11/26/2008CN100435795C Micro-powder dom peridone maleate medicinal composition and its preparing method
11/26/2008CN100435791C Solid bicyclic alcohol dispersion
11/26/2008CN100435784C Method for preparing inorganic salt nanometer particles containing and packing traditional Chinese medicine and its application
11/26/2008CN100435783C Orally administered composition containing fat soluble ingredient of red sage root
11/26/2008CN100435663C Health-care food with functions of improving immunocompetence and protecting damaged gastric mucosa and its preparing method
11/26/2008CN100435647C Pet food product and method of manufacture
11/25/2008US7457685 Preparing for individualized dosage forms of medicaments
11/25/2008US7456312 making gabapentin tannate to treat central nervous system disorders by reacting gabapentin and tannic acid; used in sustained release applications and to improve certain organoleptic properties such as taste
11/25/2008US7456306 Stearate composition and method of production thereof
11/25/2008US7456297 crystalline polymorphic dosage forms of anticholesterol agents; statins; small particle size distribution
11/25/2008US7456265 Carriers for cosmetics, pharmaceuticals, and veterinary products providing timed releasing of active ingredients
11/25/2008US7456254 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein about 3%-5% (w/w) exendin-4 and about 2% (w/w) sucrose; antidiabetic agent
11/25/2008US7456236 Adhesive for percutaneous absorption, adhesive composition for percutaneous absorption and preparation for percutaneous absorption
11/25/2008US7456207 Vaginal pharmaceutical compositions and methods for preparing them
11/25/2008US7456160 Sustained release; injection of fulvestrant; using 7 alpha -[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17 beta -diol to treat hormonal dependent benign or malignant disease of the breast or reproductive tract
11/25/2008US7456159 For delivering therapeutically effective amount of a drug that includes a parent drug and a prodrug; for delivering steroids
11/25/2008US7456155 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
11/25/2008US7456150 Pulmonary delivery of active fragments of parathyroid hormone
11/25/2008US7456147 Controlled release of active agents utilizing repeat sequence protein polymers
11/25/2008US7456009 Adenovirus formulations
11/25/2008US7455858 For use in photodynamic therapy
11/25/2008US7455857 Energy generating composition
11/25/2008US7455856 Lipid-derivatized bisphosphonic acid
11/25/2008US7455855 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance
11/25/2008US7455854 Fluid swellable fibrous matrix containing minerals; artificial bone
11/25/2008US7455849 Aqueous, non-alcoholic liquid powder formulations
11/25/2008US7455847 Storage stability, does not separate after long periods of time; e.g. sunscreen; water-in-oil emulsion with cetyl dimethicone copolyol emulsifier and a separation inhibitor comprising dimethicone cross-polymer
11/25/2008US7455843 useful for enhancing immune response to antigens; vaccines; applicable to mucosal immunization in humans
11/25/2008US7455830 Enhancing intestinal absorption of bioactive agent through epithelial cells using nanoparticles with a shell of chitosan, said bioactive agent and a core of polyglutamic acid; bioavailability of biodrugs, peptides, hormones, insulin, Alzheimer's drugs
11/25/2008US7455668 Temperature activated systems
11/25/2008US7455667 Controlled release device and method using electrothermal ablation
11/25/2008US7455248 Powder delivery device
11/25/2008CA2433032C Sustained release drug delivery devices with coated drug cores
11/25/2008CA2383212C Controlled release oral dosage suitable for oral administration
11/25/2008CA2382588C Polymorphs of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
11/25/2008CA2376791C Drug delivery device for insertion in the vagina, rectum or nasal cavity
11/25/2008CA2375549C Delivery system for biological material
11/25/2008CA2370565C Dermally applicable vitamin d-containing pharmaceutical compositions
11/25/2008CA2345354C Antisense modulation of bcl-x expression
11/25/2008CA2344680C Enteric and colonic delivery using hpmc capsules
11/25/2008CA2336376C Microparticle formulation for inhalation
11/25/2008CA2320182C Compositions containing organic compounds
11/25/2008CA2306508C Production of a directly compressible tabletting aid
11/25/2008CA2264776C Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
11/25/2008CA2221418C Insecticidal combination effective against fleas on mammals, particularly cats and dogs
11/25/2008CA2140971C A stable freeze-dried hirudin composition
11/20/2008WO2008141276A1 Anti-alpha-v immunoliposome composition, methods and uses
11/20/2008WO2008141264A1 Anti-insomnia compositions and methods
11/20/2008WO2008141059A2 Lung volume reduction therapy using crosslinked non-natural polymers
11/20/2008WO2008140853A2 Water dispersible polymer compositions
11/20/2008WO2008140834A2 Novel antimicrobial peptides
11/20/2008WO2008140772A2 Robust rapid disintegration tablet formulation
11/20/2008WO2008140594A2 Peptide nanoparticles and uses therefor
11/20/2008WO2008140507A2 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
11/20/2008WO2008140475A2 Imaging contrast agents using nanoparticles
11/20/2008WO2008140461A1 Solid form
11/20/2008WO2008140460A1 Solid form
11/20/2008WO2008140459A1 Solid form
11/20/2008WO2008140453A1 Iontophoretic devices for drug delivery
11/20/2008WO2008140444A1 Dimeric double metal salts of(-) hydroxycitric acid, methods of making and uses of same
11/20/2008WO2008140373A1 A liquid formulation for administering nicotine
11/20/2008WO2008140372A1 Coated oral nicotine formulation buffered with amino acid
11/20/2008WO2008140371A1 Oral nicotine formulation buffered with amino acid
11/20/2008WO2008140203A1 Phospholipid nanospheres for solubilization of diterpenoid alkaloid and preparation
11/20/2008WO2008140081A1 Liposome and method for producing liposome
11/20/2008WO2008139855A1 Polyamidoamine dendron-bearing lipid containing lower acyl group
11/20/2008WO2008139804A1 Low-molecule drug-containing nanoparticle having sustained release negatively charged group
11/20/2008WO2008139703A1 Agent for treatment of pulmonary disease
11/20/2008WO2008139575A1 Preparation for oral administration
11/20/2008WO2008139264A2 Soft gel formulations
11/20/2008WO2008139210A2 Process for obtaining steroidal phosphate compounds
11/20/2008WO2008139170A2 Transdermal and transmucosal drug delivery enhancers
11/20/2008WO2008139124A2 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/20/2008WO2008139122A2 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/20/2008WO2008139078A2 Gaseous mixture containing o2 and n2o for preventing or reducing hyperalgesia
11/20/2008WO2008139053A1 Multilayer spheroids with anti-malaria action and with an artesunate-containing layer
11/20/2008WO2008138816A2 Solid composition comprising a clay such as kaolin
11/20/2008WO2008138758A1 Pharmaceutical composition of an anthracycline
11/20/2008WO2008138755A2 Pharmaceutical compositions for poorly soluble drugs
11/20/2008WO2008138612A2 Substrate promoting angiogenesis
11/20/2008WO2008138571A1 Probiotic bacteria containing oral dosage form
11/20/2008WO2008138563A1 Pharmaceutical composition comprising desloratadine
11/20/2008WO2008138459A2 Aqueous pharmaceutical preparation
11/20/2008WO2008138099A1 Sensory feedback-based method for determining the bioavailability of orally administered dietary supplements
11/20/2008WO2008138085A2 Process for encapsulating chemically active substances and encapsulated product
11/20/2008WO2008121951A3 Packaged film dosage unit containing a complexate
11/20/2008WO2008106129A3 Polymeric micelles for combination drug delivery
11/20/2008WO2008104880A3 Stable solid dosage forms of an antidepressant
11/20/2008WO2008103139A3 Shea butter dimethicone copolyols
11/20/2008WO2008101147A3 Methods and compositions for regulating bone mineral density
11/20/2008WO2008097897A9 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1(pai-1)
11/20/2008WO2008095479A3 Use of a highly emulsified silicone oil (hes) for the production of a medicament
11/20/2008WO2008092084A3 Injectable non-aqueous suspension with high concentration of therapeutic agent
11/20/2008WO2008080092A3 Compositions comprising bile acid sequestrants for treating esophageal disorders
11/20/2008WO2008078102A3 Lipids and their use as non-viral delivery vehicle
11/20/2008WO2008064338A3 Valsartan formulation for pulsatile delivery
1 ... 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 ... 2991